5-hydroxymethyl-2'-deoxyuridine has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frenkel, K; Karkoszka, J; Khasak, D; Sasson, M; Shupack, JL; Stiller, MJ | 1 |
| Frenkel, K; Karkoszka, J; Khasak, D; Shupack, J; Stiller, M | 1 |
2 other study(ies) available for 5-hydroxymethyl-2'-deoxyuridine and Psoriasis
| Article | Year |
|---|---|
Antibody titers to an oxidized thymidine moiety are altered by systemic pharmacotherapy and by ultraviolet B phototherapy.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Cell Survival; Humans; Immune Complex Diseases; Molecular Structure; Oxidation-Reduction; Psoriasis; Thymidine; Titrimetry; Ultraviolet Therapy | 1993 |
Enhanced antibody titers to an oxidized DNA base in inflammatory and neoplastic diseases.
Topics: Adult; Aged; Antibodies; Antigen-Antibody Complex; Dermatitis; DNA; Female; Humans; Immune System Diseases; Male; Middle Aged; Neoplasms; Psoriasis; Reactive Oxygen Species; Thymidine; Varicose Ulcer | 1992 |